38th week of 2019 patent applcation highlights part 25 |
Patent application number | Title | Published |
20190284165 | TAU PET IMAGING LIGANDS | 2019-09-19 |
20190284166 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | 2019-09-19 |
20190284167 | COMPOUNDS | 2019-09-19 |
20190284168 | PYRAZOLE DERIVATIES AS SGC STIMULATORS | 2019-09-19 |
20190284169 | Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof | 2019-09-19 |
20190284170 | Substituted Benzimidazole Derivative as a Modulator of TNF Activity | 2019-09-19 |
20190284171 | METHOD OF CONVERTING CARBON DIOXIDE INTO CARBONYL COMPOUNDS | 2019-09-19 |
20190284172 | Urea Derivatives and Uses Thereof | 2019-09-19 |
20190284173 | TRIAZOLE PHENYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | 2019-09-19 |
20190284174 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | 2019-09-19 |
20190284175 | DEUTERATED CFTR MODULATORS | 2019-09-19 |
20190284176 | COMPOSITIONS AND METHODS FOR TREATING CARDIOMYOPATHY | 2019-09-19 |
20190284177 | HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA | 2019-09-19 |
20190284178 | TREATMENT OF NEUROLOGICAL DISORDERS | 2019-09-19 |
20190284179 | OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | 2019-09-19 |
20190284180 | HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND APPLICATION THEREOF | 2019-09-19 |
20190284181 | PRODRUGS OF NH-ACIDIC COMPOUNDS | 2019-09-19 |
20190284182 | INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF | 2019-09-19 |
20190284183 | INHIBITION OF BMP SIGNALING, COMPOUNDS, COMPOSITIONS AND USES THEREOF | 2019-09-19 |
20190284184 | NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1,5-a]PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2,3-DIOXYGENASES | 2019-09-19 |
20190284185 | SUBSTITUTED IMIDAZO[1,2-A]PYRIDIN-2-YLAMINE COMPOUNDS, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | 2019-09-19 |
20190284186 | PROCESS FOR PREPARING METHYL{4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]P- YRIMIDIN-5-YL}METHYLCARBAMATE AND ITS PURIFICATION FOR USE AS PHARMACEUTICALLY ACTIVE COMPOUND | 2019-09-19 |
20190284187 | BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS | 2019-09-19 |
20190284188 | PHARMACOPHORE FOR TRAIL INDUCTION | 2019-09-19 |
20190284189 | OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | 2019-09-19 |
20190284190 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | 2019-09-19 |
20190284191 | BICYCLIC HETEROARYL DERIVATIVES | 2019-09-19 |
20190284192 | NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2019-09-19 |
20190284193 | SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | 2019-09-19 |
20190284194 | TYK2 INHIBITORS AND USES THEREOF | 2019-09-19 |
20190284195 | ORTHO SUBSTITUTED PHENYLPYRAZOLO- AND PHENYLPYRROLO-PYRIDAZINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | 2019-09-19 |
20190284196 | BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT | 2019-09-19 |
20190284197 | PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS OF HYDROCODONE BENZOIC ACID ENOL ESTER AND PROCESSES FOR MAKING SAME | 2019-09-19 |
20190284198 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | 2019-09-19 |
20190284199 | Synthetic Process and Novel Intermediates | 2019-09-19 |
20190284200 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | 2019-09-19 |
20190284201 | BIS-DIOX(OL)ANE COMPOUNDS | 2019-09-19 |
20190284202 | PROCESS FOR THE MANUFACTURE OF DIAZEPINE DERIVATIVES | 2019-09-19 |
20190284203 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE | 2019-09-19 |
20190284204 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE | 2019-09-19 |
20190284205 | NOVEL PHARMACEUTICAL FORMULATION | 2019-09-19 |
20190284206 | SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | 2019-09-19 |
20190284207 | NOVEL ULK1 INHIBITORS AND METHODS USING SAME | 2019-09-19 |
20190284208 | N-[(2,4-DIFLUOROPHENYL)METHYL]-6-HYDROXY-3-METHYL-5,7-DIOXO-2,3,5,7,11,11a- -HEXAHYDRO[1,3]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINE-8-CARBOXAMIDE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | 2019-09-19 |
20190284209 | CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES | 2019-09-19 |
20190284210 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | 2019-09-19 |
20190284211 | CRYPTATES AND METHODS OF USE | 2019-09-19 |
20190284212 | MECHANICALLY SHAPED 2-DIMENSIONAL COVALENT ORGANIC FRAMEWORKS | 2019-09-19 |
20190284213 | SILYLATED DERIVATIVES OF RESERVATROL AND THE USE THEREOF IN NEURODEGENERATIVE, NEUROLOGICAL OR INFLAMMATORY DISEASES | 2019-09-19 |
20190284214 | PROCESS FOR PRODUCING CYCLIC HYDROGENATED SILANE COMPOUND | 2019-09-19 |
20190284215 | SIMPLE PREPARATION METHOD FOR DIALKOXYPROPYL METHYLPHOSPHONATE | 2019-09-19 |
20190284216 | Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) | 2019-09-19 |
20190284217 | NOVEL COMPOUND, COMPOSITION INCLUDING SAME, OLEFIN-BASED RESIN COMPOSITION, MOLDED ARTICLE THEREOF, AND METHOD FOR IMPROVING IMPACT RESISTANCE OF MOLDED ARTICLE | 2019-09-19 |
20190284218 | NOVEL CARBENE PRECURSOR COMPOUND AND USE THEREOF | 2019-09-19 |
20190284219 | HYDRATED AND ANHYDROUS POLYMORPHS OF 2'-O-FUCOSYLLACTOSE AND THEIR PRODUCTION METHODS | 2019-09-19 |
20190284220 | CRYSTAL FORM OF DAPAGLIFLOZIN INTERMEDIATE AND PREPARATION METHOD THEREFOR | 2019-09-19 |
20190284221 | NOVEL TRIS- OR NEOPENTYL GLYCOL-BASED AMPHIPHILES AND USES THEREOF | 2019-09-19 |
20190284222 | ANTICANCER COMPOUNDS | 2019-09-19 |
20190284223 | NOVEL POST FERMENTED TEA-DERIVED KAEMPFEROL-BASED COMPOUND | 2019-09-19 |
20190284224 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | 2019-09-19 |
20190284225 | TGR5 MODULATORS AND METHODS OF USE THEREOF | 2019-09-19 |
20190284226 | THIONYL TETRAFLUORIDE MODIFIED COMPOUNDS AND USES | 2019-09-19 |
20190284227 | Intermediates for the Synthesis of Bile Acid Derivatives, in Particular of Obeticholic Acid | 2019-09-19 |
20190284228 | METHOD FOR MODIFYING T CELL POPULATION | 2019-09-19 |
20190284229 | SUBSTITUTED STEROIDS FOR THE TREATMENT OF CANCER | 2019-09-19 |
20190284230 | ASSEMBLED GLYCOPROTEINS | 2019-09-19 |
20190284231 | PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2019-09-19 |
20190284232 | PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS | 2019-09-19 |
20190284233 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) | 2019-09-19 |
20190284234 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) | 2019-09-19 |
20190284235 | NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS | 2019-09-19 |
20190284236 | NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS | 2019-09-19 |
20190284237 | BIFUNCTIONAL PEPTIDE HAVING CAPABILITY TO REDUCE INFLAMMATION AND CAPABILITY TO FACILITATE DIFFERENTIATION OF STEM CELLS INTO CHONDROCYTES AND USE THEREOF | 2019-09-19 |
20190284238 | ANTIMICROBIAL PEPTOIDS WITH IMPROVED SELECTIVITY AND USE THEREOF | 2019-09-19 |
20190284239 | BICYCLIC PEPTIDYL INHIBITOR OF TUMOR NECROSIS FACTOR-ALPHA | 2019-09-19 |
20190284240 | CYCLIC CELL PENETRATING PEPTIDES COMPRISING BETA-HAIRPIN MOTIFS AND METHODS OF MAKING AND USING THEREOF | 2019-09-19 |
20190284241 | Neonatal Fc Receptor Binding Dimer and Methods of Use | 2019-09-19 |
20190284242 | POLYPEPTIDES FOR USE IN SELF-ASSEMBLING PROTEIN NANOSTRUCTURES | 2019-09-19 |
20190284243 | BINDING PEPTIDES | 2019-09-19 |
20190284244 | HIGH-TRANSDUCTION-EFFICIENCY RAAV VECTORS, COMPOSITIONS, AND METHODS OF USE | 2019-09-19 |
20190284245 | MICROORGANISM STRAIN AND METHOD FOR ANTIBIOTIC-FREE, FERMENTATIVE PREPARATION OF LOW MOLECULAR WEIGHT SUBSTANCES AND PROTEINS | 2019-09-19 |
20190284246 | PEPTIDE INHIBITING COLONIZATION BY PATHOGENIC BACTERIA, AND COLONIZATION INHIBITOR INCLUDING SAME | 2019-09-19 |
20190284247 | NOVEL RHTB PROTEIN VARIANTS AND THE METHOD OF PRODUCING O-PHOSPHOSERINE USING THE SAME | 2019-09-19 |
20190284248 | PEPTIDES, AND USES THEREOF | 2019-09-19 |
20190284249 | BETA-CATENIN BARCODED PEPTIDES | 2019-09-19 |
20190284250 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2019-09-19 |
20190284251 | GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF | 2019-09-19 |
20190284252 | ENGINEERED FGF1 AND FGF2 COMPOSITIONS AND METHODS OF USE THEREOF | 2019-09-19 |
20190284253 | IL2 and TNF Immunoconjugates | 2019-09-19 |
20190284254 | METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1 | 2019-09-19 |
20190284255 | PROGRAMMABLE IMMUNOCYTE RECEPTOR COMPLEX SYSTEM | 2019-09-19 |
20190284256 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS | 2019-09-19 |
20190284257 | TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF | 2019-09-19 |
20190284258 | HAEMADIPSA SYLVESTRIS ANTITHROMBOTIC PEPTIDE SYLVESTIN AND USE THEREOF | 2019-09-19 |
20190284259 | Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides | 2019-09-19 |
20190284260 | RNA-CODED ANTIBODY | 2019-09-19 |
20190284261 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE | 2019-09-19 |
20190284262 | T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR FOXP3-DERIVED PEPTIDES | 2019-09-19 |
20190284263 | IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT | 2019-09-19 |
20190284264 | USE OF BETA-CATENIN AS A BIOMARKER FOR TREATING CANCERS USING ANTI-DKK-1 ANTIBODY | 2019-09-19 |